The Nordic Opportunity: Turning Real-World Data into a Rare Disease Research Powerhouse
Over the past decade, rare diseases have gone from a niche to a major focus in pharma, thanks to regulatory incentives and advances in precision…
Laura Mäntylä21/02/2025
